Cited 0 time in
A Double-blind, Randomized, Multicenter, Placebo-Controlled, Parallel, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Lenzumestrocel (Neuronata-R® inj.) in Patients with ALS
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 오기욱 | - |
| dc.date.accessioned | 2026-06-24T13:04:52Z | - |
| dc.date.available | 2026-06-24T13:04:52Z | - |
| dc.date.issued | 2025-09-09 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/215212 | - |
| dc.title | A Double-blind, Randomized, Multicenter, Placebo-Controlled, Parallel, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Lenzumestrocel (Neuronata-R® inj.) in Patients with ALS | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | PACTALS 2025 and MND Australia Care Forum 2025 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
